- Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefitsThe newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of questions.STAT · 19d ago↗ source
- STAT+: Trump administration pursues more durable changes to science policy after setbacks in courtThe White House has proposed sweeping changes to the bedrock regulation undergirding all federal contracts, empowering the executive branch to direct research, terminate grants, and external scient…STAT · 19d ago↗ source
- Vertex's Crinetics deal points to big ambitions for cystic fibrosis leaderVertex Pharmaceuticals' $10 billion acquisition of an endocrinology startup represents the company’s clearest and boldest step toward the upper echelon of the biopharma industry. Long a biotech s…